Promoter Sachin D. Patel has disclosed an intention to acquire up to 5,25,000 equity shares of Gujarat Themis Biosyn Limited from Pharmaceutical Business Group (India) Limited. The proposed acquisition, valued at up to ₹20 Crores, will take place between July 21, 2026, and July 31, 2026, at a price of ₹382 per equity share. This inter-se transfer among the promoter group will increase Patel's stake to 2.77% from the current 2.29%, while the seller's holding will reduce to 46.54% from 47.02%.

The transaction is being conducted under Regulation 10(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The acquisition is exempt from the requirement to make an open offer under Regulation 10(1)(a)(ii). The price of ₹382 per share is within the permissible limit, not exceeding 25% of the volume weighted average market price of ₹380.37 per equity share calculated over the 60 trading days preceding the notice.

Sachin D. Patel confirmed that both the transferor and transferee have complied with applicable disclosure requirements in Chapter V of the SEBI (SAST) Regulations, 2011, during the three years prior to the proposed acquisition. The acquirer also declared that all conditions specified under Regulation 10(1)(a)(ii) regarding exemptions have been duly complied with.

A previous disclosure made on July 1, 2026, regarding the same transaction was disregarded as it could not be acted upon within the stipulated period. The new disclosure supersedes the earlier intimation. The actual number of shares acquired may be less than the proposed 5,25,000 equity shares.

Shareholding Details

Transaction Key Points

• Acquirer: Sachin D. Patel (Promoter)
• Target: Gujarat Themis Biosyn Limited
• Seller: Pharmaceutical Business Group (India) Limited
• Shares: Up to 5,25,000 equity shares (0.50%)
• Price: ₹382 per equity share
• Period: July 21, 2026 to July 31, 2026

Gujarat Themis Biosyn Limited has secured shareholder approval to raise capital through a Qualified Institutions Placement (QIP) of equity shares. The special resolution was passed with 99.98% of votes in favour, authorizing the company to issue shares to qualified institutional buyers. This approval enables the company to access funds from institutional investors to support its financial objectives.

The voting process was conducted via remote e-voting, managed by Central Depository Services (India) Limited (CDSL). The e-voting period commenced on June 9, 2026, and concluded on July 8, 2026. A total of 79,477,366 votes were cast in favour of the resolution, while 18,941 votes were cast against it. The resolution required a special majority, which was comfortably met.

Voting Breakdown

The voting results were categorized by shareholder groups, with the promoter and promoter group casting 76,557,741 votes in favour, representing 100% of their polled votes. Public institutions and non-institutional shareholders also supported the resolution, with 98.54% and 99.98% of their respective votes in favour.

Procedural Details

The postal ballot notice was dispatched electronically to shareholders on June 8, 2026. Advertisements regarding the completion of dispatch were published in the 'Western Times' (English and Gujarati editions) on June 9, 2026. The scrutinizer, CS Ketan Ravindra Shirwadkar of KRS AND CO., confirmed that the voting process was conducted in a fair and transparent manner.

The scrutinizer's report, dated July 9, 2026, validated the results and confirmed the resolution's passage. The company will now proceed with the QIP process, subject to regulatory approvals and market conditions. The detailed voting results and scrutinizer's report are available on the company's website.